Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 19, 2017

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Intubation Complication
Interventions
DRUG

Budesonide and Azithromycin

Participant with acute laryngeal injury will be randomized at discharge to either a non-drug placebo control group or a medical therapy group consisting of azithromycin 250 mg and budesonide 0.5 mg for 14 days.

OTHER

Placebo control of budesonide and azithromycin

placebos of the medications will be given for 14 days in patients randomized to the control group

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03250975 - Incidence of Acute Laryngeal Injury Following Endotracheal Intubation | Biotech Hunter | Biotech Hunter